5-ALA Radiation Damage Prevention and Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current preventive and therapeutic measures for radiation damage are inadequate, particularly for continuous low-dose exposure, radiotherapy side effects, and symptoms like inflammation, hair loss, and diarrhea, with existing methods being costly, unreliable, and lacking versatility.
Innovation Solution
The use of 5-aminolevulinic acid (5-ALA) or its derivatives, potentially combined with iron compounds, to prevent and treat radiation damage by inhibiting inflammation, improving survival rates, and alleviating hematopoietic disorders, body weight reduction, and other symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional preventive measures (stable isotopes, chelating agents) are used to minimize radiation exposure, then internal exposure is reduced, but these measures cannot prevent cancer development in continuously exposed individuals or side effects in radiotherapy patients
Solution Approach 1:
5-ALA serves multiple functions: it acts as a photodynamic therapy agent for tumor treatment, provides protective effects against radiation-induced damage, and can be used in both preventive and therapeutic contexts. This single compound addresses multiple radiation-related conditions including cancer prevention in continuously exposed individuals and side effect management in radiotherapy patients, thereby achieving universality across different application scenarios.
2Reliability
If bone marrow transplantation or cytokine administration is used to treat bone marrow suppression, then hematopoietic function is restored, but these methods are costly, complex, and not universally applicable
Solution Approach 1:
5-ALA is a simple, chemically stable compound that can be administered orally or by other non-invasive routes, replacing complex and expensive treatments like bone marrow transplantation. The compound acts as a short-term protective and therapeutic agent that restores hematopoietic function without requiring complex medical procedures, making it accessible and applicable in broader settings.
3Power
If high doses of radiation are administered for cancer radiotherapy, then tumor control is improved, but side effects such as inflammation, hair loss, and diarrhea increase
Solution Approach 1:
5-ALA acts as a protective intermediary substance that mitigates the harmful effects of high-dose radiation on normal tissues. When administered to patients undergoing radiotherapy, it reduces inflammation, prevents hair loss, and alleviates gastrointestinal side effects like diarrhea, thereby enabling the delivery of effective high-dose radiation therapy while protecting surrounding healthy tissues from excessive damage.
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
An object of the present invention is to provide a preventive and/or therapeutic agent for radiation damage that has a novel mechanism of action and can prevent and alleviate a wide range of symptoms of radiation damage for which no therapeutic measures have been available so far, and moreover, is highly safe to humans. A preventive and/or therapeutic agent for radiation damage comprising a compound represented by the following formula (I) such as 5-aminolevulinic acid (5-ALA) or a salt thereof as an active ingredient can be used to improve the survival rate, improve body weight reduction, and alleviate hematopoietic disorder: (wherein R1 represents a hydrogen atom or an acyl group; and R2 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aryl group, or an aralkyl group).